Journal article
A Phase I, open-label study with escalating doses of intravenous PTK787/ZK 222584, a multi-VEGF receptor inhibitor, followed by multiple oral daily dosing to assess the absolute bioavailability of PTK787/ZK 222584 after single and multiple doses in advanced cancer patients
- Publication status:
- Published
Actions
Authors
Bibliographic Details
- Journal:
- EJC SUPPLEMENTS
- Volume:
- 3
- Issue:
- 2
- Pages:
- 427-427
- Publication date:
- 2005-10-01
- ISSN:
-
1359-6349
- Source identifiers:
-
125012
Item Description
- Pubs id:
-
pubs:125012
- UUID:
-
uuid:543bb4de-f2ee-41ba-9616-24f722e85081
- Local pid:
- pubs:125012
- Deposit date:
- 2013-11-16
Terms of use
- Copyright date:
- 2005
If you are the owner of this record, you can report an update to it here: Report update to this record